Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly's Taltz Approved For AS As New Guidelines Keep TNF Inhibitors In Front Line
Aug 27 2019
•
By
Mandy Jackson
Ankylosing spondylitis is the third US FDA-approved indication for Taltz. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip